David McConkey

Partner Access Infinity

David has approx. 20 years of work experience in the pharmaceutical industry. After leaving Oxford University, where he studied Biological Sciences, David moved into pharmaceutical consultancy, working for a number of leading agencies such as IQViA (then IMS), McCann Healthcare (Double Helix Consulting) and Ipsos (GKF Bridgehead) as he built his skill set in pricing and market access. However, the larger portion of his career has been spent working on the manufacturer side, working in ViiV Healthcare, and then Gilead Sciences. Across both companies, David has worked at all levels of the access ladder (local/country level, regional and global). David has led on HTA negotiations in the UK and Ireland, developed health economic materials and supporting communications, generated launch and pricing strategies for novel drugs, led on cross country affiliate engagement, presented to leadership all the way up to C-Suite and more. David has been deeply involved in early pipeline BD assessments, peri-launch leadership and life-cycle management, and has developed launch strategies, set pricing policy, and led on evidence generation planning.